melanotan ii purchase Melanotan-2 (MT-II) 10mg MELANOTAN II | Vi Corpus

Ongoing phase I and II clinical trials are examining the prevention and treatment of erythropoietic protoporphyria, congenital erythropoietic porphyria, solar urticaria, and polymorphous light eruption, as well as the prevention of actinic keratosis and epidermal carcinoma in transplant recipients

Mechanism of Action Melanotan 1 has been investigated for its potent and selective agonism of the melanocortin 1 receptor (MC1R), a Gs-coupled GPCR expressed on melanocytes and other cell types

Weights: Hen -26 oz

GN, granulocyte

** This product has been developed and manufactured in accordance with the requirements of EN 17444 as of the production date of the batch

Hultman American Journal of Physiology-Endocrinology and Metabolism 1994 266:5, E725-E730 Baker JS, McCormick MC, Robergs RA